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Abstract 
Background: An alternative translated product of the ENO1 gene, known as MBP-1 (c-myc 
promoter binding protein-1), acts as a negative regulator of the c-MYC oncogene, ERBB2 and 
COX-2 genes (1-3). The ENO1 gene is located in chromosomal region 1p36.2 (4), within the 
common region of deletion detected in Neuroblastoma (NB) often associated with 
amplification of MYCN gene (5). Previous studies have shown that the level of MYCN 
expression is correlated with the growth (6-8) and invasiveness (9) of Neuroblastoma cells 
and its downregulation could inhibit cell proliferation and induce differentiation and 
apoptosis. Also it has been reported that ENO1/MBP-1 overexpression in Neuroblastoma 
cells significantly reduces cell growth and induces apoptosis (4). 
Even though there are structural and functional similarities between c-MYC and MYCN 
oncogenes, there are no evidences that MBP-1 is able to interact with MYCN promoter to 
regulate negatively its expression and to act as an oncosuppressor protein in Neuroblastoma 
cells. 
 
Methodology and Findings: We induced MBP-1 overexpression in LAN-5 Neuroblastoma 
cell line, characterized by MYCN amplification, and we performed luciferase reporter assays 
on MYCN promoter in order to verify the direct effect of MBP-1 on that promoter. 
These studies have identified a promoter region involved in the negative regulation of MYCN 
by MBP-1, and its binding activity, within the MYCN promoter, was confirmed both in vitro 
and in vivo, by EMSA and chromatin-immunoprecipitation (ChIP) assays.  
qRT-PCR and Western blot analysis have shown that MBP-1 overexpression in LAN-5 cells 
determines a decrease of MYCN expression and a significant increase of p21 and BAX levels, 
involved in senescence and apoptosis respectively, and γ-enolase expression, a marker of 
neuronal differentiation. 
Scratch wound healing and proliferation assays in LAN-5 cell line have indicated that MBP-1 
expression also leads to a significant reduction of cell migration and proliferation. 
Furthermore, by cytotoxicity assay has been shown that MBP-1 expression induces a 
cytotoxic and pro-apoptotic effect in MYCN-amplified cells.  
The analysis of expression profiles of mRNAs and microRNAs, using microarray technology, 
has confirmed the data obtained from the studies conducted in LAN-5 cells expressing MBP-
1 and identified pathways involved in the regulation of apoptosis, in cell growth and in cell 
migration. 
 
Conclusions: The results obtained indicate that MBP-1 acts as a transcriptional repressor of 
MYCN gene and its expression induces senescence, apoptosis and differentiation in LAN-5 
Neuroblastoma cells.  
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